IGM Biosciences of Mountain View, Calif. — nestled in the Silicon Valley between San Francisco and San Jose — is relocating one of its headquarters to the greener pastures of Doylestown. John George reported the eastbound moving vans for the Philadelphia Business Journal.

IGM is relocating two business units to the Pennsylvania Biotechnology Center of Bucks County in Doylestown: IGM Infectious Diseases and IGM Autoimmunity and Inflammation. With them are expected a staff of as many as 30 scientists and other employees.

“The Pennsylvania Biotechnology Center has proven itself to be an excellent environment for life sciences companies, and we’re very pleased to be opening an operation in close proximity to Philadelphia, New York, and Boston,” said Dr. Mary Beth Harler, president of IGM Autoimmunity and Inflammation. “This region offers a wealth of expertise and experience in the biotech and pharmaceutical sectors, and we look forward to establishing a presence in this area.”

Dr. Tong-Ming Fu, chief scientific officer of IGM Infectious Diseases, said the expansion provides the company with dedicated lab space to create “exciting new therapies for a multitude of indications beyond oncology.”

More on the east-coast operations of IGM Biosciences is at the Philadelphia Business Journal.